Aerodynamics Engineering

Viventia Biotech Inc., located in Mississauga, ON, is a biopharmaceutical company focused on developing innovative oncology therapies through its proprietary Targeted Protein Therapeutics (TPT) technology. Their advanced product candidates include ViciniumTM, aimed at treating high-grade non-muscle invasive bladder cancer, and ProxiniumTM, designed for late-stage squamous cell carcinoma of the head and neck. The company's robust pipeline consists of fully biologic fusion constructs that combine the precision targeting of antibody fragments with the tumor-killing power of protein toxins. With additional early-stage products in development, Viventia is committed to advancing its clinical-stage portfolio to address significant unmet medical needs in cancer treatment. Generated from the website